Hosted on MSN17d
GSK buys US-based rare cancer treatment developer for up to £1bn
according to the American Cancer Society. GSK’s acquisition of IDRx will include IDRX-42 which is currently being developed and trialled as therapy for the treatment of gastrointestinal stomal ...
Yahoo Finance3d
GSK and Oxford researchers to create cancer vaccine to stop disease developing
Pharmaceutical giant GSK and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or vaccines which target ...
The Independent3d
Cancer vaccine being created by UK scientists could stop disease up to 20 years early
Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American ... The GSK-Oxford Cancer Immuno ...